Bain Capital related stories
All articles and analysis
Biotech VC Ascenta raises $325m for Fund IThe multi-medicine biotechnology investor is led by a pair of MDs who share an alma mater.
A silver lining in Q3 private equity fundraisingTime spent on the road by GPs marketing their funds fell in this year’s first three quarters, according to Buyouts data, the first such drop since the slowdown began.
Bain closes $14bn flagship after 'one of the largest distribution years ever'The firm has returned billions in capital to investors since early 2024, according to the firm’s co-head of North America private equity.
Bain Capital racks up $14bn for fourteenth PE fundBain Capital targets five core markets—consumer, healthcare, industrials, services and technology.
Bain-backed Frontline Road Safety snaps up Peek Pavement MarkingFrontline is a Denver-based provider of pavement marking services.
PE zeroes in on patient engagement tech: Seven dealsBain Capital, Blackstone, KKR and Advent International are among the PE firms buying or selling patient engagement technology assets.
Healthcare has robust tailwinds from demographics all around the globe, finds Bain & Co'The optimism around stability is probably higher than I've heard it has been at any other time in the last couple of years,' said Bain & Co's Nirad Jain as the firm releases new healthcare PE report.
KKR looks to leverage growth of biopharma royalties with HCRx'We’re seeing a lot of capital needs not only across the therapeutic side of life sciences but also this biopharma ecosystem of all of the companies that serve these biopharma businesses,' said KKR's Ali Satvat.
Bain-backed Crestwell Underwriters debutsBased in Tampa, Crestwell is a managing general agent that provides property insurance for condominium associates based in Florida.
PE targets immunotherapy: Five dealsBain Capital, 65 Equity Partners, Arlington Capital Partners and Revelstoke Capital Partners are among the PE firms investing in the immunotherapy sector.